Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Ear Nose Throat J ; 101(10_suppl): 40S-43S, 2022 Dec.
Article in English | MEDLINE | ID: covidwho-2162155

ABSTRACT

Internal maxillary artery (IMA) pseudoaneurysms are rare, and typically occur following trauma or orthognathic surgery. Pseudoaneurysms are life-threatening conditions, and expeditious workup and treatment is critical. Endoscopic treatment of an IMA pseudoaneurysm is a feasible option and should be considered when IR embolization is not available. The objective of this study is to review the literature on IMA pseudoaneurysms and present the first reported case of an IMA pseudoaneurysm successfully treated endoscopically.


Subject(s)
Aneurysm, False , Embolization, Therapeutic , Humans , Maxillary Artery , Aneurysm, False/diagnostic imaging , Aneurysm, False/etiology , Aneurysm, False/surgery , Endoscopy
2.
Am J Otolaryngol ; 41(5): 102617, 2020.
Article in English | MEDLINE | ID: covidwho-603943

ABSTRACT

BACKGROUND: The COVID-19 pandemic has radically shifted healthcare operations within hospitals and universities across the globe. However, the effect of the COVID-19 pandemic on research endeavors and clinical trials is unclear. OBJECTIVE: This study investigates the impact of the COVID-19 pandemic on basic science and clinical research within the rhinology community. METHODS: A cross-sectional study was designed utilizing an 8-question survey to identify changes to rhinology research. Questions evaluated the impact of the COVID-19 pandemic on administrative research support and staffing, basic science research, clinical trials and resident research involvement. RESULTS: Seventy-one participants responded to the survey (8.5% response rate). Most respondents noted changes in IACUC/IRB approval (faster, 33%; slower, 31%). Of those who employed laboratory personnel, 64% were able to continue staff employment with full salary. The majority of animal research and in vitro studies were halted (64% and 56%, respectively), but animal care and cell line maintenance were allowed to continue. Clinical trial enrollment was most commonly limited to COVID derived studies (51%). Forty-seven percent of respondents noted increased resident research participation. CONCLUSION: The rapid spread of the SARS-CoV-2 virus has markedly impacted rhinology-related research. Maintaining safe workplace practices as restrictions are lifted will hopefully mitigate the spread of the virus and allow research productivity to resume.


Subject(s)
Betacoronavirus , Biomedical Research/organization & administration , Biomedical Research/statistics & numerical data , Coronavirus Infections/epidemiology , Otolaryngology , Pneumonia, Viral/epidemiology , COVID-19 , Cross-Sectional Studies , Humans , Pandemics , SARS-CoV-2 , Societies, Medical , Surveys and Questionnaires , United States
SELECTION OF CITATIONS
SEARCH DETAIL